Filtered By:
Education: University of Pennsylvania
This page shows you your search results in order of relevance. This is page number 3.
Order by Relevance | Date
Total 50 results found since Jan 2013.
$10 million gift to UCLA from Wendy and Leonard Goldberg is largest ever to support migraine research
UCLA Health Sciences has received a $10 million gift, most of which will support multidisciplinary research on migraine, a debilitating neurological disorder that affects 36 million people in the U.S.
The gift was made by philanthropists Wendy and Leonard Goldberg. Wendy Goldberg is an editor and author; her husband, Leonard, is an award-winning film and television producer and executive.
More than 90 percent of sufferers are unable to work during their migraine attacks, costing employers $13 billion a year in lost work days; and every 10 seconds, someone in the U.S. goes to an emergency room with a migraine-related compla...
Source: UCLA Newsroom: Health Sciences - December 8, 2015 Category: Universities & Medical Training Source Type: news
InVivo Therapeutics Q2 meets the street, shares stay steady
InVivo Therapeutics (NSDQ:NVIV) shares stayed steady after the company released 2nd quarter earnings that met the street on losses per share.
The Cambridge, Mass.-based company reported losses of $5.2 million, or 16¢ per share, for the 3 months ended June 30, 2016. That amounts to a 50% reduction in losses for InVivo Therapeutics compared with same period in 2015.
After adjusting to exclude 1-time items, losses per share were 18¢, a good tick below what analysts on Wall Street were looking for with expectations set fro losses of 22¢ per share.
“The 2nd quarter was one marked by continued advancements and outreach...
Source: Mass Device - August 5, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Neurological Spinal InVivo Therapeutics Corp. Source Type: news
Validation of olfactory deficit as a biomarker of Alzheimer disease
Conclusions:
Olfactory identification deficit is a useful screening tool for AD-related amnestic disorder, with sensitivity and specificity comparable to other established biomarkers, with benefits such as ease of administration and low cost. Olfactory identification deficit can be utilized to stratify risk of conversion from aMCI to AD and enrich clinical trials of disease-modifying therapy.
Classification of evidence:
This study provides Class III evidence that smell identification (10-item UPSIT subset) accurately identifies patients with amnestic disorders.
Source: Neurology Clinical Practice - February 12, 2017 Category: Neurology Authors: Woodward, M. R., Amrutkar, C. V., Shah, H. C., Benedict, R. H. B., Rajakrishnan, S., Doody, R. S., Yan, L., Szigeti, K., On behalf of the Texas Alzheimer Research and Care Consortium Tags: Alzheimer's disease, Class III, MCI (mild cognitive impairment) Research Source Type: research
Donald Trump Thinks Exercise Is Bad For You
Nothing is safe from alternative facts ― even exercise.
According to Donald Trump, physical fitness is useless. As the Washington Post’s Michael Kranish and Marc Fisher wrote in their new book, Trump Revealed, Trump believes a sweat session actually does more harm than good:
After college, after Trump mostly gave up his personal athletic interests, he came to view time spent playing sports as time wasted. Trump believed the human body was like a battery, with a finite amount of energy, which exercise only depleted. So he didn’t work out.
The book also states that when Trump learned that one of his...
Source: Healthy Living - The Huffington Post - May 1, 2017 Category: Consumer Health News Source Type: news
Medtronic readies pivotal trial in renal denervation
Medtronic (NYSE:MDT) said today that it’s ready for a run at FDA approval for renal denervation in treating high blood pressure, more than three years after the failure of a high-profile clinical trial.
Back in January 2014, Fridley, Minn.-based Medtronic shocked medtech when it announced that the highly anticipated Symplicity HTN-3 trial, examining ablation of the around the renal arteries in treating hypertension, failed to meet its efficacy endpoint. The company suspended enrollment in its other Symplicity trials around the world and later took a $200 million write-down on its renal denervation assets. News of th...
Source: Mass Device - August 28, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Cardiovascular Clinical Trials Wall Street Beat Medtronic Renal Source Type: news
Care for the elderly needs to be better targeted by the health system and social networks
Vani S. Kulkarni is a Lecturer in Sociology, University of Pennsylvania, U.S.; Raghav Gaiha is (Hon.) Professorial Research Fellow, Global Development Institute, University of Manchester, U.K.By Vani S. Kulkarni and Raghav GaihaPHILADELPHIA and NEW DELHI, Sep 28 2017 (IPS)The National Health Policy (NHP), 2017 is unable to see the wood for the trees. Life and death questions are dealt with perfunctorily or simply overlooked. For example, it overlooks the rapid rise in the share of the old (60 years or more), and associated morbidities, especially sharply rising non-communicable diseases (NCDs) and disabilities. With rising...
Source: IPS Inter Press Service - Health - September 28, 2017 Category: International Medicine & Public Health Authors: S Kulkami Tags: Aid Asia-Pacific Headlines Health Human Rights Source Type: news
Falling off the health-care radar
Vani S. Kulkarni is a Lecturer in Sociology, University of Pennsylvania, U.S.; Raghav Gaiha is (Hon.) Professorial Research Fellow, Global Development Institute, University of Manchester, U.K.By Vani S. Kulkarni and Raghav GaihaPHILADELPHIA and NEW DELHI, Sep 28 2017 (IPS)Care for the elderly needs to be better targeted by the health system and social networks. The National Health Policy (NHP), 2017 is unable to see the wood for the trees. Life and death questions are dealt with perfunctorily or simply overlooked. For example, it overlooks the rapid rise in the share of the old (60 years or more), and associated morbiditie...
Source: IPS Inter Press Service - Health - September 28, 2017 Category: International Medicine & Public Health Authors: S Kulkami Tags: Aid Asia-Pacific Headlines Health Human Rights TerraViva United Nations Source Type: news
How Genomic Research is Changing Heart Care
Genomic testing is most frequently associated with cancer testing, but this area of research is beginning to make an impact on cardiovascular care. A recent scientific statement by the American Heart Association shined a spotlight on how the expressed genome can potentially be used to diagnose diseases and predict who will develop diseases such as coronary artery disease (CAD), stroke, heart failure, and arrhythmias.
According to the statement, scientists now have the ability to address disease at many levels that were inaccessible during the past century. This includes the genome, transcriptome, epigenome, proteome, metab...
Source: MDDI - October 27, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: IVD Cardiovascular Source Type: news
Winter babies are more at risk of a stroke in later life
Researchers from the University of Pennsylvania found mothers whose first trimesters were during summer are more likely to have children with irregular heartbeats as they were exposed to air pollution.
Source: the Mail online | Health - November 15, 2017 Category: Consumer Health News Source Type: news
Insurance company requirements place heavy administrative burden on physicians seeking to prescribe new cholesterol-lowering drugs
(University of Pennsylvania School of Medicine) A rare glimpse into the prior authorization requirements implemented by public and private insurance providers across the country has found substantial administrative burden for a new class of medications for patients with high cholesterol that places them at high risk for heart attack or stroke, according to new research.
Source: EurekAlert! - Medicine and Health - January 16, 2018 Category: International Medicine & Public Health Source Type: news
EuroPCR 2018 Roundup: Medtronic touts BP reductions, no major adverse events in renal denervation trial
Medtronic (NYSE:MDT) today released six-month results from a trial of its Symplicity Spyral renal denervation system exploring its use treating hypertensive patients who are already taking anti-hypertension medications, touting significant reductions in blood pressure and no major adverse safety events.
Results were presented at the 2018 EuroPCR annual meeting in Paris and were published in The Lancet.
In the trial, patients were prescribed up to three anti-hypertensive medications, including diuretics, calcium channel blockers, ACE/ARB inhibitors or beta blockers, the Fridley, Minn.-based company said. Patients were then...
Source: Mass Device - May 23, 2018 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Cardiac Implants Cardiovascular Clinical Trials Abbott Medtronic ReCor Medical Source Type: news
Characterization of Parkinson ’s disease using blood-based biomarkers: A multicohort proteomic analysis
ConclusionsIn this study, we found that the blood-based biomarkers BSP, OMD, ACY1, and GHR robustly associated with PD across multiple clinical sites. Our findings suggest that biomarkers based on a peripheral blood sample may be developed for both disease characterization and prediction of future disease progression in PD.
Source: PLoS Medicine - October 10, 2019 Category: Internal Medicine Authors: Marijan Posavi Source Type: research
Taller people have increased risk for developing atrial fibrillation
(University of Pennsylvania School of Medicine) Taller people have an increased risk of developing atrial fibrillation (AFib), an irregular and often rapid heartbeat that can lead to stroke, heart failure and other complications, according to a new Penn Medicine study. The research, which reveals a strong link between the genetic variants associated with height and one's risk for AFib, is the among the first to demonstrate that height may be a causal -- not correlated -- risk factor for AFib.
Source: EurekAlert! - Social and Behavioral Science - November 13, 2019 Category: International Medicine & Public Health Source Type: news
Five Ways To Improve Your Mental Health In 2020
(CNN) — It’s a difficult birth for this new decade. The year 2020 kicks off under the shadow of divisive politics, international security threats, a spate of hate crimes, and a planet in environmental peril, plus all the reasons we’re stressed individually: work, health problems, life changes and more.
No wonder so many of us are anxious or depressed.
But you can take scientifically validated steps to improve your mental outlook, and — because the mind and body are entwined — these behaviors also will improve your overall health.
1. Practice optimism
The studies are positive: Looking on the br...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 4, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health CNN Mental Health Source Type: news
Risk for Acute Cerebrovascular Events Low in COVID-19 Patients
MONDAY, Aug. 3, 2020 -- For hospitalized COVID-19 patients, the risk for acute cerebrovascular events is low, according to a study published online July 20 in Stroke.
Aaron Rothstein, M.D., from the University of Pennsylvania in Philadelphia, and...
Source: Drugs.com - Pharma News - August 3, 2020 Category: Pharmaceuticals Source Type: news
